Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 4 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.


Player Avatar TerryHoodSr (62.62) Submitted: 5/27/2013 3:52:38 PM : Outperform Start Price: $7.90 SPPI Score: -24.97

5 YR REV growth 90%

Featured Broker Partners